Key Takeaway
Tirzepatide and Contrave are both used for weight loss but produce very different results. Compare their mechanisms, efficacy, side effects, and costs.
Tirzepatide produces roughly three to four times more weight loss than Contrave (18-22% vs 5-8%), representing the widest efficacy gap between any two commonly prescribed weight loss medications on the market today.
Contrave and tirzepatide sit at opposite ends of the weight loss medication spectrum. Contrave, an oral combination pill, was once considered a solid option for patients seeking prescription-strength appetite control. Tirzepatide, the dual-action injectable, has raised the bar so high that every other weight loss drug looks modest by comparison. At FormBlends, we want patients to understand both options and choose based on their specific needs and circumstances.
| Feature | Tirzepatide | Contrave |
|---|---|---|
| Active Ingredients | Tirzepatide | Naltrexone + bupropion |
| Drug Class | Dual GIP/GLP-1 receptor agonist | Opioid antagonist + antidepressant |
| Administration | Weekly injection | Oral tablets (twice daily) |
| Average Weight Loss | ~18-22% | ~5-8% |
| Blood Sugar Benefits | Significant (approved for type 2 diabetes) | Minimal |
| Boxed Warnings | Thyroid C-cell tumors (animal data) | Suicidal thoughts and behaviors |
| Typical Monthly Cost | $1,000-$1,200/mo (brand) (brand) / $200-$600 (compounded) | Contact provider for current pricing |
How Tirzepatide Works
Tirzepatide activates two incretin hormone receptors: GLP-1 and GIP. This dual mechanism produces thorough metabolic effects that no other single medication matches .
GLP-1 receptor activation suppresses appetite centrally in the brain, slows gastric emptying to prolong fullness, and enhances insulin secretion. GIP receptor activation adds benefits for fat metabolism, insulin sensitivity, and may amplify the appetite-reducing effects of GLP-1 through complementary neural pathways.
The combined result is profound and sustained appetite reduction. Patients consistently report that their relationship with food fundamentally changes. Portions shrink naturally, cravings diminish, and the constant mental focus on food fades. These effects build over weeks as the dose increases through six levels, from 2.5 mg up to 15 mg. Tirzepatide is available as Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for chronic weight management). Both products contain the compounded formulation, and compounded tirzepatide through providers like FormBlends offers compounded formulations of the active ingredient at a lower price point.
How Contrave Works
Contrave approaches weight loss through the brain's reward and addiction pathways rather than the gut hormone system. It combines naltrexone (an opioid antagonist) with bupropion (an aminoketone antidepressant) . For a complete cost breakdown, see our compare tirzepatide prices.
View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
Bupropion acts on the hypothalamus to promote satiety and on dopamine pathways to reduce the rewarding quality of food. Naltrexone blocks opioid receptors, which prevents a feedback loop that would otherwise diminish bupropion's appetite-suppressing effects. The naltrexone component may also independently reduce the pleasure derived from eating, particularly high-sugar and high-fat foods.
Contrave is taken as oral tablets. The full dose is four tablets per day (two in the morning, two in the evening), reached gradually over a four-week titration. It's approved for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with a weight-related comorbidity. One thing that makes Contrave unique among weight loss medications is its targeting of the brain's reward system. For patients who struggle primarily with emotional eating, binge-like behaviors, or intense cravings for specific comfort foods, Contrave's mechanism addresses the root of the problem in a way that incretin-based medications like tirzepatide don't. It's the only FDA-approved weight loss drug that works through opioid and dopamine pathways simultaneously.
Efficacy Comparison: Weight Loss Results
The efficacy gap between these two medications is the largest of any common weight loss drug comparison.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation from a licensed physician.
Take the Assessment →Tirzepatide at its highest dose (15 mg) produced average weight loss of 22.5% in the SURMOUNT-1 trial[1] over 72 weeks . At the middle dose (10 mg), weight loss averaged 19.5%. Even the lowest dose (5 mg) produced 15% average weight loss. Nearly 40% of participants on the 15 mg dose lost more than 25% of their body weight.
Contrave produced average weight loss of 5-8% in the COR trial program . The best results came from COR-BMOD (which combined Contrave with intensive behavioral modification), showing about 9.3% weight loss. Without intensive behavior support, results were closer to 5-6%.
To put this in real terms: for a 250-pound patient, tirzepatide might produce 38-56 pounds of weight loss, while Contrave might produce 12-20 pounds. Both are clinically significant, but they represent very different transformations. It's also worth noting the speed of results. Tirzepatide patients often report noticeable appetite changes within the first week, with steady weight loss building month over month for a full year or more. Contrave's appetite effects kick in within the first few weeks, but the total magnitude of weight loss typically plateaus earlier. Patients on Contrave who haven't lost at least 5% of body weight by week 12 are generally advised to discontinue, as they're unlikely to see meaningful further results . Beyond weight loss, tirzepatide offers substantial metabolic benefits that Contrave doesn't. Tirzepatide significantly lowers blood sugar, improves insulin sensitivity, and may reduce cardiovascular risk. Contrave has minimal effects on blood sugar and actually raises blood pressure in some patients, which is the opposite of what most overweight patients need.
Side Effects Comparison
Tirzepatide side effects:
- Nausea (24-33%)
- Diarrhea (15-23%)
- Constipation (10-17%)
- Vomiting (during titration)
- Abdominal discomfort
- Rare: pancreatitis, gallbladder events, kidney injury
Contrave side effects:
- Nausea (common, can persist)
- Constipation
- Headache
- Insomnia
- Dry mouth
- Dizziness
- Increased blood pressure
- Boxed warning: suicidal thoughts and behaviors
The safety profiles present different risk patterns. Tirzepatide's risks are primarily gastrointestinal and metabolic. Contrave's risks include psychiatric effects (from the bupropion component) and cardiovascular concerns (blood pressure elevation). Contrave can't be used with opioid medications, in patients with seizure disorders, or in patients with uncontrolled hypertension.
Tirzepatide is generally considered to have a more favorable safety profile, particularly for patients with cardiovascular risk factors. Emerging data suggests tirzepatide may actually provide cardiovascular protection rather than risk.
Our clinical team at FormBlends takes a proactive approach to managing side effects with tirzepatide. Careful dose titration, dietary guidance during the adjustment period, and regular check-ins help most patients move through the early GI symptoms and settle into comfortable long-term use. With Contrave, the most troublesome side effects tend to be nausea (which can persist longer than with tirzepatide) and insomnia, which can affect daily functioning and quality of life.
Cost Comparison
Contrave costs approximately Contact provider for current pricing per month at brand-name pricing. Generic naltrexone/bupropion combinations are available and may cost $50 to $150 per month, making Contrave one of the more affordable prescription weight loss options.
Brand-name tirzepatide (Zepbound) costs approximately $1,000-$1,200/mo (brand) per month. Compounded tirzepatide through FormBlends costs $200 to $600 per month, which is more expensive than Contrave but delivers vastly superior results.
The value equation depends on how you measure it. Per pound of weight lost, tirzepatide often provides better value despite the higher monthly price. But for patients who only need modest weight loss or who face strict budget constraints, Contrave remains a reasonable option.
Long-term cost considerations also matter. Both medications are intended for ongoing use, as stopping either typically leads to weight regain. Contrave's lower monthly cost makes it more sustainable for budget-conscious patients, but if the weight loss results are insufficient, the money spent produces limited return. Tirzepatide's higher cost comes with dramatically better outcomes, which can translate to reduced spending on obesity-related health conditions, fewer medications for blood pressure, cholesterol, and diabetes, and improved overall quality of life.
Who Is Tirzepatide Best For?
- Patients who need substantial weight loss (20%+ of body weight)
- Those with type 2 diabetes or significant insulin resistance
- Patients who tried Contrave or other oral weight loss medications without adequate results
- Anyone comfortable with weekly injections
- Patients with seizure disorders or other contraindications to bupropion
- Those who can't take opioid-blocking medications
Who Is Contrave Best For?
- Patients who prefer oral medication and refuse injections
- Those whose weight gain is driven heavily by food cravings and emotional eating patterns
- Patients on a tight budget who need an affordable prescription option
- Those with concurrent mild-to-moderate depression who might benefit from bupropion
- Patients who need modest weight loss (5-10%) and want to avoid injectable medications
Medical References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
Can I switch from Contrave to tirzepatide?
Yes. Your physician can transition you from Contrave to tirzepatide. You would stop Contrave and start tirzepatide at the beginning of its titration schedule (2.5 mg). There's no specific overlap or wash-out period required, but discuss the timing with your doctor.
Is it possible to combine Contrave and tirzepatide?
This combination isn't well studied and isn't commonly prescribed. Since both suppress appetite through different mechanisms, the combination is theoretically additive, but it also increases the total side effect burden. This decision should be made by your physician based on your individual risk-benefit profile.
Why would anyone choose Contrave over tirzepatide?
Common reasons include preferring an oral medication, needing an affordable option, having contraindications to GLP-1 medications, or having an eating pattern driven primarily by reward-seeking and emotional eating where Contrave's mechanism may be particularly relevant.
Does FormBlends prescribe Contrave?
FormBlends specializes in GLP-1 and peptide therapies, including compounded tirzepatide and compounded semaglutide. During your consultation, our physicians can discuss all available weight loss options and help you determine the best path forward.
Ready to experience what the most effective weight loss medication can do? Start your free consultation with FormBlends today and let our physicians design a tirzepatide treatment plan tailored to your goals.